Peru approves cannabis-based drugs for cancer patients

Sativyl, a cannabis-based drug, just got approved for the treatment of cancer in Peru starting next year.

The drug is made by a Canadian pharmaceutical company, Verdemed, and is designed to work as close to Sativex as possible. Peruvian patients can now use Sativyl to relieve symptoms of cancer, as well as those suffering from spasticity from multiple sclerosis and nausea from chemotherapy. It is an antiemetic that can help improve appetite and enable them to get better results from their treatment.

Aside from these benefits, Sativyl is said to provide excellent pain relief without containing any opioids. It is a good substitute for the harmful and addicting opioids that caused thousands of deaths worldwide due to the opioid epidemic. The health license was issued by Peruvian officials in less than a month after the Brazilian health authority handed Verdemed over for the distribution of full-spectrum CBD at 50 mg / ml, another treatment they are working with Clever Leaves, an American-Colombian company, have developed.

Sativyl is made at a concentration of 27 mg / ml THC in combination with 25 mg / ml CBD. It can be purchased bottle-wise at a concentration of 10 mg or 250 mg. It is made in Canada together with the Toronto Institute of Pharmaceutical Technology. “In January next year we will have sativyl on the Peruvian market,” explains Jose Bacellar, CEO of Verdemed. “We believe it’s a third of Mevatyl. will cost [the Brazilian version of Sativex], comes to just R $ 500 [$89.60]. “

There is a need for medicinal cannabis in Peru

In October 2021, Cannahope Medical Center and QF Farmacia Magistral signed an agreement that would make it easier for low-income patients to access medical cannabis. Peru’s Cannabis Studies Center says medicinal cannabis would benefit up to 7 million patients across the country, which is why both Cannahope and QF Farmacia Magistral have started offering 10 free consultations a month for low-income patients.

They would also provide cannabis oil for free.

Max Alzamora, a specialist in endocannabinoid medicine and co-founder of Cannahope, told Peru 21: “The United Nations and various studies have recognized that the medicinal properties of cannabis relieve chronic pain by up to 50% in patients who consume it can. The more than 1,200 patients we have treated at Cannahope have proven it. ”He adds that 70% of patients who went there enjoyed relief from at least one of their symptoms.

Wilson Ccarhuaypina, Pharmacy Project Manager, said, “We pride ourselves on improving the quality of life for dozens of patients who need and cannot afford cannabis. For each of them, as well as for all of our customers, we will offer personalized pharmaceutical care and high-quality medication so that they can feel relieved. “

Cannabis in Latin America

This news is wonderful for the Peruvian community, which is soon to catch up with the rest of Latin America when it comes to cannabis.

It wasn’t until Uruguay fully legalized cannabis in 2013 that South America was put under the microscope by the cannabis world. Uruguay was the first country in the world, and not just South America, to create a national legal market for the medicinal and recreational use of cannabis. It is clear, however, that the United States played a major role in these changes within the South American legal system; In 2012, there were 11 states plus the District of Columbia that had approved recreational or medicinal use.

As early as 2017, the legislature in Peru voted with an overwhelming majority for the legalization of the medical use of cannabis and finally allowed the local production of cannabis oil as well as its import and sale. It followed a government proposal to decriminalize medical cannabis as a treatment for incurable diseases after a police raid in February 2017 discovered a makeshift laboratory used by mothers to make cannabis oil to treat their sick children.

Today, medical cannabis in one form or another is legalized in numerous Latin American countries, including Peru, Brazil, Argentina, Mexico, Colombia, Chile, and Paraguay, aside from Uruguay. In addition, Ecuador has already changed its criminal code to allow cannabis to be used for therapeutic purposes. Even so, the legislative changes across the region regarding the cannabis law are still icy at best.

The legal cannabis industry in Latin America is already valued at $ 9.75 billion, with tremendous growth potential and economic benefits for the continent that lost 26 million jobs at the start of the pandemic. All over the world, cannabis has proven to be a cash cow, and Latin America certainly needs a piece of the pie.

It just makes perfect sense to make Latin America a cannabis hub. Prohibition Partners ‘2nd Edition of the Prohibition Partners’ Latin America and Caribbean Cannabis Report said the region’s low construction and labor costs could cut cannabis production costs by up to 80% compared to North America. This already gives them a significant advantage.

MEDICAL CANNABIS AND CANCER, READ MORE …

RICK SIMPSON OIL AND CANCER, THE LEGEND TALKS TO CANNABIS.NET!

OR..

WHY STRONGER THC STRAINS ARE RECOMMENDED FOR CANCER PATIENTS